Does hypnotherapy actually work? What the research says
Last updated: March 2026
Most people assume hypnotherapy is either a magic bullet or complete pseudoscience. Neither is true. The reality sits in a much more interesting place — and in 2024, we have more data than ever to map exactly where hypnotherapy works, where it doesn’t, and where the jury is still out.
A 2024 umbrella review in Frontiers in Psychology analyzed 49 meta-analyses covering 261 primary studies and over two decades of controlled research (Rosendahl et al., 2024). This article breaks down what that body of evidence actually says — condition by condition, with effect sizes, limitations, and what it means for someone deciding whether to try hypnotherapy.
The short answer
Yes, hypnotherapy works — but not for everything, not for everyone, and not equally well across conditions.
The strongest evidence exists for pain management and irritable bowel syndrome (IBS), where multiple high-quality meta-analyses show consistent, clinically meaningful effects. For anxiety, the evidence is strong but most studies focus on procedural anxiety rather than diagnosed anxiety disorders. For smoking, weight loss, and depression, the picture is more complicated — some studies show benefits, others don’t, and the quality of evidence is often lower.
The rest of this article goes through each condition individually, because “does hypnotherapy work?” is the wrong question. The right question is: does it work for this specific thing?
Pain — the strongest evidence
If there’s one area where hypnotherapy has proven itself, it’s pain management. This is where the largest number of studies exist, the methodology is strongest, and the results are most consistent.
A 2025 systematic review of 20 RCTs involving 1,250 patients found that hypnosis significantly reduced pain during invasive medical procedures compared to standard care, with an effect size of SMD = −0.35 (95% CI: −0.50 to −0.20, p < 0.001). The same review found significant reductions in procedure-related anxiety (SMD = −0.43) and physiological stress markers including heart rate and blood pressure. Adverse effects were minimal (Walter et al., 2025).
The Rosendahl et al. (2024) umbrella review, which synthesized findings across all conditions, found that pain-related outcomes had the highest certainty ratings of any domain — two outcomes received “high certainty” ratings from the included reviews, a distinction that no other condition achieved. A separate large meta-analysis covering 85 trials and 3,632 patients concluded that hypnosis is both a safe and effective alternative to pharmaceutical pain management (Thompson et al., 2019, cited in Rosendahl et al., 2024).
The evidence covers surgical pain, burn pain, cancer-related pain, labor pain, dental procedures, and chronic pain conditions including fibromyalgia. For anyone considering hypnotherapy specifically for pain, the research is about as supportive as it gets for a complementary therapy.
Irritable bowel syndrome — recommended by NICE
Gut-directed hypnotherapy (GDH) for IBS is one of the clearest success stories in the hypnotherapy evidence base. It’s the only application where a major national health guideline body — the UK’s National Institute for Health and Care Excellence (NICE) — explicitly recommends hypnotherapy as a treatment option for patients who haven’t responded to first-line therapies.
A 2025 systematic review and meta-analysis of 12 studies involving 1,158 IBS patients found that gut-directed hypnotherapy improved global IBS symptoms with an effect size of SMD = 0.73 and significantly reduced abdominal pain (SMD = 0.25). All 12 studies found hypnotherapy superior to comparators; nine reached statistical significance. Group delivery was as effective as individual sessions (Adler et al., 2025).
A separate 2025 network meta-analysis published in The Lancet Gastroenterology & Hepatology, covering 67 trials and 7,441 patients, ranked digital gut-directed hypnotherapy third among all behavioral therapies for IBS in terms of immediate post-treatment efficacy — behind only minimal-contact self-management and cognitive therapy (Lancet Gastro & Hepatology, 2025).
The dropout rate across GDH studies was notably low (pooled rate of 8%), suggesting high tolerability. Improvements in quality of life, anxiety, and depression symptoms were also consistently reported as secondary outcomes.
Anxiety — strong but with caveats
The evidence for hypnotherapy and anxiety is substantial, but comes with an important distinction: most studies examine procedural anxiety (anxiety before medical procedures, dental work, surgery) rather than diagnosed anxiety disorders like GAD or social anxiety disorder.
Valentine et al. (2019) conducted the most comprehensive anxiety-specific meta-analysis to date — 15 studies incorporating 17 trials. The results showed a mean weighted effect size of d = 0.79 at the end of treatment and d = 0.99 at the longest follow-up, meaning effects actually increased over time. Hypnotherapy combined with other treatments (particularly CBT) produced larger effects than hypnotherapy alone (Valentine et al., 2019).
These are meaningful effect sizes — comparable to established psychological treatments. But the caveat matters: the included trials mostly targeted test anxiety, dental anxiety, medical procedure anxiety, and performance anxiety. Large-scale RCTs comparing hypnotherapy to SSRIs or CBT for formally diagnosed GAD or social anxiety disorder are still lacking. The evidence is promising, not yet definitive for clinical anxiety diagnoses. For practical guidance, see our full guide on hypnotherapy for anxiety.
Smoking, weight, depression — where evidence gets complicated
Not all hypnotherapy claims are equally supported. For three commonly marketed applications — smoking cessation, weight loss, and depression — the evidence is more mixed than popular claims suggest.
Smoking cessation. Hypnotherapy is frequently marketed for quitting smoking, and some individual studies show positive results. However, the Rosendahl et al. (2024) umbrella review noted that the certainty of evidence for smoking cessation was rated as “low” in the included reviews. A Cochrane review found no clear advantage for hypnotherapy over other interventions or no treatment. Results appear to depend heavily on the specific protocol used and individual hypnotizability. Hypnotherapy may help some people quit smoking, but the research doesn’t support it as a reliably effective standalone treatment.
Weight loss. The situation is similar. Some studies report modest weight loss with hypnotherapy — particularly when used alongside behavioral interventions — but effect sizes are small and long-term follow-up data is limited. Hypnotherapy for weight management works best as an adjunct to dietary and exercise changes, not a replacement. See: hypnotherapy for weight loss.
Depression. A 2024 systematic review of RCTs on hypnotherapy for major depressive disorder found “very low-quality evidence” — the authors concluded that hypnosis-based interventions cannot yet be clinically recommended for depression based on current data (Souza et al., 2024). One notable finding: cognitive hypnotherapy was comparable to CBT in some trials, but the overall evidence was insufficient due to small sample sizes and methodological concerns.
This doesn’t mean hypnotherapy is ineffective for these conditions. It means the research hasn’t yet demonstrated consistent, reliable effects at a standard that would warrant clinical recommendation. More and better studies are needed.
The evidence at a glance
What the major health organizations say
The credibility of any therapy depends partly on whether mainstream medical institutions take it seriously. For hypnotherapy, the picture is increasingly favorable — though with qualifications.
The National Center for Complementary and Integrative Health (NCCIH), part of the US National Institutes of Health, identified hypnotherapy in 2021 as a treatment with “high programmatic priority” and issued dedicated funding announcements for clinical trials — the first since 2015. The NCCIH specifically recognizes evidence for hypnosis in treating IBS, chronic pain, PTSD, and hot flashes (NCCIH, 2021).
The UK’s NICE recommends gut-directed hypnotherapy for IBS patients who haven’t responded to pharmacological therapies after 12 months. The American Psychological Association’s Division 30 (Society of Psychological Hypnosis) recognizes hypnosis as a legitimate therapeutic tool and has published standardized definitions and research guidelines. The British Medical Association acknowledged hypnotherapy as a legitimate therapeutic technique as early as 1955, and the position has only strengthened since.
What no organization says: that hypnotherapy is a standalone treatment for any condition, or that it should replace conventional treatment. Every major endorsement positions it as a complementary therapy — an addition to, not a substitute for, standard medical care.
The limitations you should know about
Honest reporting of evidence means being transparent about its gaps. Several limitations affect the hypnotherapy research literature as a whole.
Sample sizes are often small. Many RCTs include fewer than 50 participants per arm, which limits statistical power and the reliability of conclusions. The Rosendahl et al. (2024) umbrella review flagged this as a consistent issue across conditions.
Protocols vary widely. There is no single standardized “hypnotherapy” — different studies use different induction techniques, suggestion content, session lengths, and numbers of sessions. This heterogeneity makes it difficult to compare results across studies or to know exactly which version of hypnotherapy produced which effect.
Blinding is inherently difficult. You can’t give someone a placebo hypnotherapy session without them knowing. This means most hypnotherapy trials compare against waitlist controls, standard care, or attention controls — not true placebo. The inability to blind participants inflates the risk that expectation effects (believing the treatment will work) contribute to positive outcomes.
Publication bias is likely. Studies showing positive results are more likely to be published than null results. Several of the included meta-analyses in Rosendahl et al. (2024) did not formally assess publication bias. Head-to-head comparisons with established treatments — comparing hypnotherapy directly against CBT, SSRIs, or other proven interventions — remain uncommon.
None of these limitations invalidate the evidence. They contextualize it. The consistent finding across dozens of meta-analyses — that hypnotherapy produces small-to-medium positive effects for pain, IBS, and anxiety — is robust enough to survive these methodological concerns. But it does mean that claims of large effects or universal applicability should be treated with appropriate skepticism.
How to evaluate hypnotherapy claims yourself
Given the mixed evidence landscape, here’s a practical framework for assessing any claim about hypnotherapy — whether from a practitioner, a website, or an app marketing page.
Ask what condition the claim refers to. “Hypnotherapy works” is meaningless without specifying for what. As the evidence table above shows, effectiveness varies dramatically by condition. Pain management and IBS have strong support. Depression does not.
Look for specific research citations. Credible claims reference specific studies — ideally meta-analyses or systematic reviews, not individual case reports or testimonials. If a practitioner or product can’t point to peer-reviewed research for their specific claim, that’s a red flag.
Check the source type. PubMed, Cochrane, NICE, and APA publications carry more weight than blog posts, social media, or manufacturer websites. Our editorial guidelines explain the source hierarchy we use at HypnoNews.
Be wary of absolute language. “Cures,” “guarantees,” “proven to fix” — these terms don’t belong in evidence-based health communication. Legitimate claims use hedged language: “research suggests,” “studies indicate,” “evidence shows.” That’s not weakness — it’s scientific honesty. For more on evaluating practitioners, see: is hypnotherapy safe?
Where hypnotherapy research is heading
The field is moving faster than at any point in its history. The NCCIH’s 2021 funding priority designation is already producing new trials. Several trends suggest the evidence base will look substantially different within the next five years.
Digital delivery is expanding access and study scale. App-based hypnotherapy (particularly for IBS and sleep) enables larger, more diverse study populations than traditional clinic-based trials. The 2025 Lancet network meta-analysis already ranks digital gut-directed hypnotherapy among the most effective behavioral IBS treatments — a finding that would have been impossible a decade ago.
Neuroimaging is providing mechanistic evidence. fMRI and EEG studies are mapping how hypnosis affects brain networks involved in attention, pain perception, and emotional regulation. This isn’t just academic — mechanistic evidence strengthens the case for clinical adoption by showing how hypnotherapy works, not just that it works.
The conditions most likely to see stronger evidence in the near future are chronic pain (where large multi-site trials are underway), anxiety disorders (where clinical anxiety-specific trials are needed), and sleep (where self-hypnosis interventions are showing particular promise). For a practical look at the apps leading this digital shift, see our best hypnotherapy apps guide.
Frequently asked questions
Is hypnotherapy scientifically proven?
Why do some people say hypnotherapy doesn't work?
Usually because they’re thinking of stage hypnosis or expecting a cure-all. Hypnotherapy doesn’t work for everything, it doesn’t work the same for everyone (individual hypnotizability varies), and it’s not a standalone replacement for conventional treatment. When people try hypnotherapy for a condition where evidence is weak, or with a poorly trained practitioner, negative experiences are unsurprising.
How does hypnotherapy compare to CBT?
For anxiety, both are supported by evidence. CBT has a larger overall research base, but hypnotherapy shows comparable effect sizes in the studies that exist. The Valentine et al. (2019) meta-analysis found that combining hypnotherapy with CBT produced better results than either alone. They’re not competitors — they’re complementary. See: hypnotherapy vs CBT.
Can hypnotherapy work if I'm skeptical?
What conditions have the best evidence?
This article is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Hypnotherapy is a complementary therapy and should not replace evidence-based medical treatment. The evidence summaries in this article reflect the current state of research and may change as new studies are published. Always consult a qualified healthcare provider before starting any new therapy.
Sources
1. Rosendahl, J., Alldredge, C. T., & Haddenhorst, A. (2024). Meta-analytic evidence on the efficacy of hypnosis for mental and somatic health issues: a 20-year perspective. Frontiers in Psychology, 14, 1330238. DOI: 10.3389/fpsyg.2023.1330238
2. Walter, N., et al. (2025). Hypnosis as a non-pharmacological intervention for invasive medical procedures — systematic review and meta-analytic update. Journal of Psychosomatic Research, 192, 112117. DOI: 10.1016/j.jpsychores.2025.112117
3. Adler, E. C., et al. (2025). Gut-directed hypnotherapy for irritable bowel syndrome: a systematic review and meta-analysis. Neurogastroenterology & Motility, 37(7), e70037. DOI: 10.1111/nmo.70037
4. Lancet Gastroenterology & Hepatology (2025). Efficacy of behavioural therapies for irritable bowel syndrome: a systematic review and network meta-analysis. The Lancet Gastro & Hepatology
5. Valentine, K. E., Milling, L. S., Clark, L. J., & Moriarty, C. L. (2019). The efficacy of hypnosis as a treatment for anxiety: a meta-analysis. International Journal of Clinical and Experimental Hypnosis, 67(3), 336–363. DOI: 10.1080/00207144.2019.1613863
6. Souza, F. L., et al. (2024). Hypnotherapy for major depressive disorder: a systematic review of randomized clinical trials. Complementary Therapies in Clinical Practice, 54, 101810. DOI: 10.1016/j.ctcp.2024.101810
7. Elkins, G. R., Barabasz, A. F., Council, J. R., & Spiegel, D. (2015). Advancing research and practice: The revised APA Division 30 definition of hypnosis. International Journal of Clinical and Experimental Hypnosis, 63(1), 1–9. DOI: 10.1080/00207144.2014.961870
8. National Center for Complementary and Integrative Health (2021). Mind and Body Approaches for Health: New Clinical Trials. NCCIH
This website is for informational and educational purposes only. The content on HypnoNews does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any new therapy, including hypnotherapy.